Key facts
- This page summarizes Steve E. Krognes's Form 4 filing for Denali Therapeutics Inc. (DNLI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 08 Jan 2025, 20:23.
Steve E. Krognes - 07 Jan 2025 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)
- Reporting relationship
- Director
- Issuer ticker
- DNLI
- Reported as of
- 07 Jan 2025
- Net transaction value
- -$69,485
- SEC form
- 4
- Accepted by SEC
- 08 Jan 2025, 20:23:57 UTC
- Prior SEC filing
- 02 Jan 2025
- Next SEC filing
- 04 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tyler Nielsen, by power of attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Steve E. Krognes filed Form 4 for Denali Therapeutics Inc. (DNLI) on 08 Jan 2025.
Change
- Previous filing in this sequence was filed on 02 Jan 2025.
- Current net transaction value: -$69,485.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DNLI
transaction
Common Stock
Sale
- Transaction value
- $69,485
- Shares
- -3,339
- Change %
- -11%
- Price
- $20.81
- Shares after
- 25,757
- Date
- 07 Jan 2025
- Ownership
- Direct
- Footnotes
- F1, F2
DNLI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 781,797
- Date
- 07 Jan 2025
- Ownership
- See footnote
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.
Footnote F2
Includes 5,967 Unvested RSUs.
Footnote F3
The shares are held of record by The Steve Edward Krognes Revocable Trust U/A DTD 01/25/2016, for which the Reporting Person serves as trustee.